Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

HIV Infection

Free Subscription Articles published in J Virol Retrieve available abstracts of 377 articles: HTML format

Single Articles

July 2008
1. TOUSSAINT H , Gobert FX, Schindler M, Banning C, et al
   HIV-1 Nef expression prevents AP-2-mediated internalization of the MHC II-associated invariant chain.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. MATTHEWS PC , Prendergast A, Leslie A, Crawford H, et al
   CENTRAL ROLE OF REVERTING MUTATIONS IN HLA ASSOCIATIONS WITH HIV VIRAL SETPOINT.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. TEE KK , Pybus OG, Li XJ, Han X, et al
   Temporal and Spatial Dynamics of the Human Immunodeficiency Virus Type 1 Circulating Recombinant Forms 08_BC and 07_BC in Asia.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. MYERS RE , Pillay D
   Analysis of Natural Sequence Variation and Covariation in Human Immunodeficiency Virus Type-1 Integrase.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. HUARTE N , Lorizate M, Maeso R, Kunert R, et al
   THE BROADLY NEUTRALIZING ANTI-HIV-1 4E10 MONOCLONAL ANTIBODY IS BETTER ADAPTED TO MEMBRANE-BOUND EPITOPE RECOGNITION AND BLOCKING THAN 2F5.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. CENTLIVRE M , Klaver B, Berkhout B, Das AT, et al
   Functional Analysis of the Complex TAR RNA Structure in Simian Immunodeficiency Virus.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. DEHART JL , Bosque A, Harris R, Planelles V, et al
   "HIV-1 Vif induces cell cycle delay via recruitment of the same E3 ubiquitin ligase complex that targets APOBEC3 proteins for degradation"
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. SUNDSTROM M , White RL, de Parseval A, Sastry KJ, et al
   Mapping of the CXCR4 Binding site within Variable Region 3 of the Feline Immunodeficiency Virus Surface Glycoprotein.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. ZHOU Y , Shen L, Yang HC, Siliciano RF, et al
   Preferential Cytolysis of Peripheral Memory CD4+ T Cells by In Vitro X4-tropic HIV-1 Infection Before the Completion of Reverse Transcription.
   J Virol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   June 2008
10. HAUPT S , Donhauser N, Chaipan C, Schuster P, et al
    CD4 Binding Affinity Determines HIV-1 Induced Plasmacytoid Dendritic Cell Interferon Alpha Production.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. CHASE AJ , Yang HC, Zhang H, Blankson JN, et al
    Preservation of FoxP3+ Regulatory T Cells in the Peripheral Blood of HIV-1-infected Elite Suppressors Correlates with Low CD4+ T-cell Activation.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. CHEN J , Pathak VK, Peng W, Hu WS, et al
    Capsid Proteins from Human Immunodeficiency Virus Type 1 and Simian Immunodeficiency Virus SIVmac can Coassemble into Mature Cores of Infectious Viruses.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. SUN Y , Santra S, Schmitz JE, Roederer M, et al
    Magnitude and Quality of Vaccine-elicited T Cell Responses in the Control of Immunodeficiency Virus Replication in Rhesus Monkeys.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. ALTER G , Rihn S, Streeck H, Teigen N, et al
    Ligand independent exhaustion of Killer immunoglobulin-like receptor+ CD8+ T cells in HIV-1 infection.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. BRITTLE EE , Wang F, Lubinski JM, Bunte RM, et al
    A Replication Competent, Neuronal Spread Defective, Live Attenuated Herpes Simplex Virus Type-1 Vaccine.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. MIURA T , Brockman MA, Brumme CJ, Brumme ZL, et al
    Genetic Characterization of Human Immunodeficiency Virus type 1 in Elite Controllers: Lack of gross genetic defects or common amino acid changes.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. STANLEY BJ , Ehrlich ES, Short L, Yu Y, et al
    Structural Insight into the HIV Vif SOCS Box and Its Role in Human E3 Ubiquitin Ligase Assembly.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. GUMBI PP , Nkwanyana NN, Bere A, Burgers WA, et al
    Impact of mucosal inflammation on cervical HIV-1-specific CD8 T cell responses in the female genital tract during chronic HIV infection.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. JENNES W , Camara M, Dieye T, Mboup S, et al
    Higher Homologous and Lower Cross-Reactive Gag-Specific T-cell Responses in Human Immunodeficiency Virus Type 2 (HIV-2) Compared to HIV-1 Infection.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
20. CHANG KW , Oh J, Alvord WG, Hughes SH, et al
    The Effects of Alternate Polypurine Tracts (PPTs) and Mutations of Sequences Adjacent to the PPT on Viral Replication and Cleavage Specificity of the Rous Sarcoma Virus Reverse Transcriptase.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. ARMITAGE AE , Katzourakis A, de Oliveira T, Welch JJ, et al
    Conserved footprints of APOBEC3G on hypermutated HIV-1 and HERV-K(HML2) sequences.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. LAND AM , Ball TB, Luo M, Pilon R, et al
    HIV-1 Proviral Hypermutation Correlates with CD4 Count in HIV Infected Women from Kenya.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. MARTINS AN , Medeiros SO, Simonetti JP, Schatzmayr HG, et al
    Phylogenetic and genetic analysis of Feline Immunodeficiency Virus gag, pol and env genes from domestic cats under NRTI treatment or treatment-naive circulating in Rio de Janeiro, Brazil.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. JABLONSKI JA , Buratti E, Stuani C, Caputi M, et al
    The secondary structure of the HIV-1 transcript modulates viral splicing and infectivity.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. MITCHELL RS , Chaudhuri R, Lindwasser OW, Tanaka KA, et al
    A Competition Model for the Upregulation of the MHC-II Associated Invariant Chain by HIV-1 Nef.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. VAN MONTFORT T , Thomas AA, Pollakis G, Paxton WA, et al
    Dendritic Cells Preferentially Transfer CXCR4 using Human Immunodeficiency Virus Type 1 Variants to CD4+ T Lymphocytes in trans.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
27. JIANG W , Lederman MM, Mohner RJ, Rodriguez B, et al
    Impaired naive and memory B cell responsiveness to TLR9 stimulation in HIV-infection.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. COX KS , Clair JH, Prokop MT, Sykes KJ, et al
    DNAgag/Ad5gag and Ad5gag/Ad5gag Vaccines Induce Distinct T cell Response Profiles.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. NICOL MQ , Mathys JM, Pereira A, Ollington K, et al
    HIV infection alters TNF{alpha} production via TLR-dependent pathways in Alveolar Macrophages and U1 cells.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. BUNNIK EM , Pisas L, van Nuenen AC, Schuitemaker H, et al
    Autologous Neutralizing Humoral Immunity and Evolution of the Viral Envelope in the Course of Subtype B Human Immunodeficiency Virus Type 1 Infection.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
31. PANDREA I , Onanga R, Souquiere S, Mouinga-Ondeme A, et al
    Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding.
    J Virol. 2008;82:5501-9.
    PubMed     Related articles    Abstract available
    
    
    
32. DIOP OM , Ploquin MJ, Mortara L, Faye A, et al
    Plasmacytoid dendritic cell dynamics and alpha interferon production during Simian immunodeficiency virus infection with a nonpathogenic outcome.
    J Virol. 2008;82:5145-52.
    PubMed     Related articles    Abstract available
    
    
    
33. VEAZEY RS , Acierno PM, McEvers KJ, Baumeister SH, et al
    Increased loss of CCR5+ CD45RA- CD4+ T cells in CD8+ lymphocyte-depleted Simian immunodeficiency virus-infected rhesus monkeys.
    J Virol. 2008;82:5618-30.
    PubMed     Related articles    Abstract available
    
    
    
34. FRANK I , Stossel H, Gettie A, Turville SG, et al
    A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells.
    J Virol. 2008;82:5329-39.
    PubMed     Related articles    Abstract available
    
    
    
35. KIM EY , Veazey RS, Zahn R, McEvers KJ, et al
    Contribution of CD8+ T cells to containment of viral replication and emergence of mutations in Mamu-A*01-restricted epitopes in Simian immunodeficiency virus-infected rhesus monkeys.
    J Virol. 2008;82:5631-5.
    PubMed     Related articles    Abstract available
    
    
    May 2008
36. GASPER-SMITH N , Crossman DM, Whitesides JF, Mensali N, et al
    Induction of Plasma (TRAIL), TNFR-2, Fas Ligand and Plasma Microparticles After HIV-1 Transmission: Implications for HIV-1 Vaccine Design.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
37. SANTOS-VELAZQUEZ J , Kim B
    dNTP Incorporation Mechanism of Foamy Virus (FV) Reverse Transcriptase: Implications for Cell Tropism of FV.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
38. RUGGIERO E , Bona R, Muratori C, Federico M, et al
    Virological Consequences of Early Events Following the Cell-Cell Contact between HIV-1 Infected and Uninfected CD4+ Cells.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
39. WANG H , Sun J, Goldstein H
    HIV-1 Infection Increases the In Vivo Capacity of Peripheral Monocytes to Cross the Blood Brain Barrier into the Brain and the In Vivo Sensitivity of the Blood Brain Barrier to Disruption by LPS.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
40. TSIBRIS AM , Sagar M, Gulick RM, Su Z, et al
    In vivo emergence of vicriviroc resistance in an HIV-1 subtype C-infected subject.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
41. FUJITA M , Otsuka M, Miyoshi M, Khamsri B, et al
    Vpx is critical for the reverse transcription of human immunodeficiency virus type 2 genome in macrophages.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
42. SKASKO M , Kim B
    Compensatory Role of Human Immunodeficiency Virus Central Polypurine Tract Sequence for Kinetically Disrupted Reverse Transcription.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
43. VAINE M , Wang S, Crooks ET, Jiang P, et al
    Improved induction of antibodies against key neutralizing epitopes by HIV-1 gp120 DNA prime-protein boost vaccination compared to gp120 protein only vaccination.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
44. BAILEY JR , O'Connell K, Yang HC, Han Y, et al
    Transmission of HIV-1 from a Patient Who Developed AIDS to an Elite Suppressor.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
45. TASCA S , Ho SH, Cheng-Mayer C
    R5X4 viruses are evolutionary, functional and antigenic intermediates in the pathway of SHIV coreceptor switch.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
46. DOBROWSKY TM , Zhou Y, Sun SX, Siliciano RF, et al
    Monitoring Early Fusion Dynamics of Human Immunodeficiency Virus Type 1 at Single-Molecule Resolution.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
47. BALDWIN C , Berkhout B
    Mechanistic studies on a T20-dependent HIV-1 variant.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
48. BERRO R , Pedati C, Kehn-Hall K, Wu W, et al
    CDK13: A NEW POTENTIAL HIV-1 INHIBITORY FACTOR REGULATING VIRAL mRNA SPLICING.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
49. HOOK LM , Huang J, Jiang M, Hodinka R, et al
    Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
50. ZHANG MY , Vu BK, Choudhary A, Lu H, et al
    Cross-Reactive Human Immunodeficiency Virus Type 1- Neutralizing Human Monoclonal Antibody which Recognizes A Novel Conformational Epitope on gp41 and Lacks Reactivity against Self Antigens.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
51. LI K , Zhang S, Kronqvist M, Wallin M, et al
    Intersubunit disulfide isomerization controls membrane fusion of human T-cell leukemia virus Env.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
52. SEKI S , Kawada M, Takeda A, Igarashi H, et al
    Transmission of simian immunodeficiency virus carrying multiple cytotoxic T-lymphocyte escape mutations with diminished replicative ability can result in AIDS progression in rhesus macaques.
    J Virol. 2008;82:5093-8.
    PubMed     Related articles    Abstract available
    
    
    
53. BISSEL SJ , Wang G, Bonneh-Barkay D, Starkey A, et al
    Systemic and brain macrophage infections in relation to the development of simian immunodeficiency virus encephalitis.
    J Virol. 2008;82:5031-42.
    PubMed     Related articles    Abstract available
    
    
    
54. LANGLOIS MA , Neuberger MS
    Human APOBEC3G can restrict retroviral infection in avian cells and acts independently of both UNG and SMUG1.
    J Virol. 2008;82:4660-4.
    PubMed     Related articles    Abstract available
    
    
    April 2008
55. BANSAL A , Jackson B, West K, Wang S, et al
    Multifunctional T cell characteristics induced by a polyvalent DNA prime/protein boost HIV-1 vaccine regimen given to healthy adults are dependant upon the route and dose of administration.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
56. KNOEPFEL SA , Salisch NC, Huelsmann PM, Rauch P, et al
    Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant HIV-1 reverse transcriptase variants.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
57. RULLI SJ JR , Mirro J, Hill SA, Lloyd P, et al
    INTERACTIONS OF MURINE APOBEC3 AND HUMAN APOBEC3G WITH MURINE LEUKEMIA VIRUSES.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
58. KELLER PW , Johnson MC, Vogt VM
    Mutations in SP and adjoining sequences in Rous sarcoma virus Gag lead to tubular budding.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
59. LUALLEN RJ , Lin J, Fu H, Cai KK, et al
    An engineered Saccharomyces cerevisiae strain binds the broadly neutralizing HIV-1 antibody 2G12 and elicits mannose-specific, gp120 binding antibodies.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
60. MESQUITA PM , Wilson SS, Manlow P, Fischetti L, et al
    Candidate Microbicide PPCM Blocks HIV-1 Infection in Cell and Tissue Cultures and Prevents Genital Herpes in a Murine Model.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
61. AMBROSE Z , Compton L, Piatak M Jr, Lu D, et al
    Incomplete Protection Against SIV Vaginal Transmission in Rhesus Macaques by a Topical Antiviral Agent Revealed by Repeat Challenges.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
62. YUE FY , Merchant A, Kovacs CM, Loutfy M, et al
    Viral specific IL-17 producing CD4+ T cells are detectable in early HIV-1 infection.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
63. ROUSSEAU CM , Daniels MG, Carlson JM, Kadie C, et al
    HLA Class-I Driven Evolution of Human Immunodeficiency Virus Type 1 Subtype C Proteome: Immune Escape and Viral Load.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
64. CHOI EI , Reimann KA, Letvin NL
    In vivo natural killer cell depletion during primary SIV infection in rhesus monkeys.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
65. ASTRONOMO RD , Lee HK, Scanlan CN, Pantophlet R, et al
    A glycoconjugate antigen, based on the recognition motif of a broadly-neutralising HIV antibody, 2G12, is immunogenic but elicits antibodies unable to bind to the 'self' glycans of gp120.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
66. BANDARANAYAKE RM , Prabu-Jeyabalan M, Kakizawa J, Sugiura W, et al
    Structural Analysis of HIV-1 CRF01_AE Protease in Complex with the Substrate p1-p6.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
67. EGGINK D , Baldwin CE, Deng Y, Langedijk JP, et al
    Selection of T1249-resistant Human Immunodeficiency Virus type 1 variants.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
68. HE Y , Chen J, Li J, Qi Z, et al
    Identification of a Critical Motif for the HIV-1 gp41 Core Structure: Implication for Designing Novel Anti-HIV Fusion Inhibitors.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
69. MAJUMDER B , Venkatachari NJ, O'Leary S, Ayyavoo V, et al
    Vpr positive Human Immunodeficiency Virus (HIV-1) infection impairs NK cell function indirectly through cytokine dysregulation of infected target cells.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
70. KRATOVAC Z , Virgen CA, Bibollet-Ruche F, Hahn BH, et al
    Primate lentivirus capsid sensitivity to TRIM5 proteins.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
71. ARFI V , Riviere L, Jarrosson-Wuilleme L, Goujon C, et al
    CHARACTERIZATION OF THE EARLY STEPS OF INFECTION OF PRIMARY BLOOD MONOCYTES BY HIV-1.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
72. KOZISEK M , Saskova KG, Rezacova P, Brynda J, et al
    Ninety Nine is Not Enough: Molecular Characterization of Inhibitor Resistant HIV-1 Protease Mutants with Insertions in the Flap Region.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
73. MULKY A , Cohen TV, Kozlov SV, Korbei B, et al
    The LEM domain proteins emerin and LAP2{alpha} are dispensable for HIV-1 and MLV infection.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
74. MURRAY SM , Picker LJ, Axthelm MK, Hudkins K, et al
    Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
75. KRAFT Z , Strouss K, Sutton WF, Cleveland B, et al
    Characterization of Neutralizing Antibody Responses Elicited by Clade A Envelope Immunogens Derived from Early Transmitted Viruses.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
76. DUENAS-DECAMP MJ , Peters P, Burton D, Clapham PR, et al
    Natural HIV-1 resistance to the CD4bs antibody, b12, conferred by a glycan and an arginine residue close to the CD4 binding loop.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
77. KEELE BF , Tazi L, Gartner S, Liu Y, et al
    Characterization of the Follicular Dendritic Cell Reservoir of HIV-1.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
78. MANESS NJ , Yant LJ, Chung C, Loffredo JT, et al
    Comprehensive immunological evaluation of elite controller and progressor, Mamu-B*17-positive SIV-infected rhesus macaques reveals surprisingly few differences.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
79. KAMATA M , Watanabe N, Nagaoka Y, Chen IS, et al
    HIV-1 Vpr binds to the N-lobe of Wee1 kinase domain and enhances kinase activity for Cdc2.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
80. ZHOU Y , Rong L, Lu J, Pan Q, et al
    The insulin-like growth factor II mRNA binding protein 1 associates with the Gag protein of human immunodeficiency virus type 1 and its overexpression affects virus assembly.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
81. SCHNEIDEWIND A , Brockman MA, Sidney J, Wang YE, et al
    Structural and Functional Constraints Limit Options for CTL Escape in the Immunodominant HLA-B27 Restricted Epitope in HIV-1 Capsid.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
82. YAP MW , Lindemann D, Stanke N, Reh J, et al
    Restriction of foamy viruses by primate Trim5{alpha}
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
83. VISHWANATHAN SA , Hunter E
    The Membrane-Proximal External Region (MPER) of HIV-1 gp41-Importance of its Membrane-Perturbing Properties to Viral Fusion.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
84. LITTLE SJ , Frost SD, Wong JK, Smith DM, et al
    The Persistence of Transmitted Drug Resistance among Subjects with Primary HIV Infection.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
85. STRATOV I , Chung A, Kent SJ
    Robust NK-cell mediated HIV-specific antibody-dependent responses in HIV-infected subjects.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
86. HUANG W , Toma J, Fransen S, Stawiski E, et al
    Coreceptor Tropism can be Influenced by Amino Acid Substitutions in the gp41 Transmembrane Subunit of Human Immunodeficiency Virus Type 1 Envelope Protein.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
87. LIU J , Kjeken R, Mathiesen I, Barouch DH, et al
    Recruitment of Antigen-Presenting Cells to the Site of Inoculation and Augmentation of HIV-1 DNA Vaccine Immunogenicity by In Vivo Electroporation.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
88. TAYLOR BM , Foulke JS, Flinko R, Heredia A, et al
    An Alteration of HIV gp41 Leading to Reduced CCR5 Dependence and CD4 Independence.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
89. SUN J , Zheng JH, Zhao M, Lee S, et al
    Increased In Vivo Activation of Microglia and Astrocytes in the Brains of Mice Transgenic for an Infectious R5 HIV-1 Provirus and for CD4-specific Expression of Human Cyclin T1 In Response To LPS Stimulation.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
90. EMU B , Sinclair E, Hatano H, Ferre A, et al
    HLA Class I-Restricted T Cell Responses May Contribute to the Control of HIV Infection, but Such Responses are Not Always Necessary for Long-term Virus Control.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
91. SHANG L , Yue L, Hunter E
    Role of the Membrane-spanning Domain of Human Immunodeficiency Virus Type I Envelope Glycoprotein in Cell-cell Fusion and Virus Infection.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
92. LIU J , Ewald BA, Lynch DM, Denholtz M, et al
    Magnitude and Phenotype of Cellular Immune Responses Elicited by Recombinant Adenovirus Vectors and Heterologous Prime-Boost Regimens in Rhesus Monkeys.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
93. MCWILLIAMS MJ , Julias JG, Hughes SH
    Mutations in the HIV-1 PPT Reduce the Rate of PPT Cleavage and Plus Strand DNA Synthesis.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
94. LUDWIG C , Leiherer A, Wagner R
    Importance of protease cleavage sites within and flanking HIV-1 transframe protein p6* for spatiotemporal regulation of protease activation.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
95. RUIZ-MATEOS E , Pelchen-Matthews A, Deneka M, Marsh M, et al
    CD63 is not Required for the Production of Infectious Human Immunodeficiency Virus Type 1 in Human Macrophages.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
96. USAMI Y , Popov S, Popova E, Gottlinger HG, et al
    Efficient and Specific Rescue of Human Immunodeficiency Virus Type 1 Budding Defects by a Nedd4-like Ubiquitin Ligase.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
97. CHUNG HY , Morita E, von Schwedler U, Muller B, et al
    NEDD4L Overexpression Rescues Release and Infectivity of HIV-1 Constructs Lacking PTAP and YPXL Late Domains.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
98. HAEDICKE J , de Los Santos K, Goff SP, Naghavi MH, et al
    The ERM family member ezrin regulates stable microtubule formation and retroviral infection.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
99. KAWADA S , Goto T, Haraguchi H, Ono A, et al
    Dominant Negative Inhibition of Human Immunodeficiency Virus Particle Production by the Non-myristoylated Form of Gag.
    J Virol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
100. LONG BR , Ndhlovu LC, Oksenberg JR, Lanier LL, et al
     KIR3DS1 Conferral of Enhanced Natural Killer Cell Function in Early HIV-1 Infection.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
101. RINGROSE J , Jeeninga RE, Berkhout B, Speijer D, et al
     Proteomic studies reveal coordinated changes in T cell expression patterns upon HIV-1 infection.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
102. PETRAVIC J , Loh L, Kent SJ, Davenport MP, et al
     CD4+ Target cell availability determines the dynamics of immune escape and reversion in vivo.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
103. VERHOEVEN D , Sankaran S, Silvey M, Dandekar S, et al
     Antiviral Therapy During Primary SIV Infection Fails to Prevent Acute CD4+ T-cell Loss In Gut Mucosa But Enhances Their Rapid Restoration Through Central Memory T-cells.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
104. EXLINE CM , Feng Z, Stoltzfus CM
     NEGATIVE AND POSITIVE mRNA SPLICING ELEMENTS ACT COMPETITIVELY TO REGULATE HIV-1 VIF GENE EXPRESSION.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
105. DUVAL M , Posner MR, Cavacini LA
     A Bispecific Antibody composed of a Non-Neutralizing Antibody to the gp41 Immunodominant Region and an anti-CD89 antibody Directs Broad HIV Destruction by Neutrophils.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
106. WEILER AM , Li Q, Duan L, Kaizu M, et al
     Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-associated SIVmac239.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
107. MANSFIELD K , Lang SM, Gaudin MC, Sanford HB, et al
     VACCINE PROTECTION BY LIVE ATTENUATED SIMIAN IMMUNODEFICIENCY VIRUS IN THE ABSENCE OF HIGH TITER ANTIBODY RESPONSES AND HIGH FREQUENCY CELLULAR IMMUNE RESPONSES MEASUREABLE IN THE PERIPHERY.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
108. PASTORI C , Clivio A, Diomede L, Consonni R, et al
     Two amino acid substitutions within first external loop of CCR5 induce HIV blocking antibodies in mice and chicken.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
109. SALIM A , Ratner L
     Modulation of {beta}-Catenin and E-Cadherin Interaction by Vpu Increases HIV-1 Particle Release.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
110. TILTON JC , Manion MM, Luskin MR, Johnson AJ, et al
     HIV Viremia Induces Plasmacytoid Dendritic Cell Activation In Vivo and Diminished Interferon-{alpha} Production In Vitro.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
111. SALAZAR-GONZALEZ JF , Bailes E, Pham KT, Salazar MG, et al
     Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single Genome Amplification and Sequencing.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
112. KAUR A , Di Mascio M, Barabasz A, Rosenzweig M, et al
     Dynamics of T- and B-lymphocyte turnover in a natural host of simian immunodeficiency virus.
     J Virol. 2008;82:1084-93.
     PubMed     Related articles    Abstract available
     
     
     January 2008
113. VAN GULCK ER , Vanham G, Heyndrickx L, Coppens S, et al
     Efficient in vitro expansion of HIV-specific T cell responses by gag mRNA-electroporated dendritic cells from treated and untreated HIV-1-infected individuals.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
114. DAUCHER M , Price DA, Brenchley JM, Lamoreaux L, et al
     Virological Outcome After Structured Interruption of Antiretroviral Therapy For HIV Infection is Associated with the Functional Profile of Virus-Specific CD8+ T-Cells.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
115. HUBER M , von Wyl V, Ammann CG, Kuster H, et al
     Potent HIV-Neutralizing and Complement Lysis Activity of Antibodies Are Not Obligatorily Linked.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
116. CAMERINI V , Decimo D, Balvay L, Pistello M, et al
     A 'dormant' IRES controls translation of the Feline Immunodeficiency Virus (FIV).
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
117. SADAGOPAL S , Amara RR, Kannanganat S, Sharma S, et al
     Expansion and exhaustion of T cell responses during mutational escape from long-term viral control in two DNA/MVA vaccinated and SHIV-89.6P challenged macaques.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
118. PANDREA I , Ribeiro RM, Gautam R, Gaufin T, et al
     SIVagm Dynamics in African Green Monkeys.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
119. LEE AW , Sharp ER, O'Mahony A, Rosenberg MG, et al
     Single cell, phosphoepitope-specific analysis demonstrates cell type- and pathway-specific dysregulation of Jak/STAT and MAPK signaling associated with in vivo HIV-1 infection.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
120. GORDON SN , Dunham RM, Engram JC, Estes J, et al
     Short-lived infected cells support virus replication in naturally SIV-infected sooty mangabeys: implications for AIDS pathogenesis.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
121. SGARBANTI M , Remoli AL, Marsili G, Ridolfi B, et al
     IRF-1 Is Required for Full NF-{kappa}B Transcriptional Activity at the HIV-1 LTR Enhancer.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
122. LI Z , Blissard GW
     Functional Analysis of the Transmembrane (TM) Domain of the AcMNPV GP64 Protein: Substitution of Heterologous TM Domains.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
123. HACHIYA A , Kodama EN, Sarafianos SG, Schuckmann MM, et al
     Amino Acid Mutation N348I in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Multi-class Resistance to Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitors.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
124. DEGOTTARDI MQ , Specht A, Metcalf B, Kaur A, et al
     Selective Downregulation of Rhesus Macaque and Sooty Mangabey MHC Class I Molecules by Nef Alleles of the SIVsmm/mac and HIV-2 Lineage.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
125. GAO Y , Lobritz MA, Roth J, Abreha M, et al
     Targets of siRNA restriction during Human Immunodeficiency Virus Type 1 replication.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
126. BALAMURUGAN A , Lewis MJ, Kitchen CM, Robertson MN, et al
     Primary HIV-1 Infection During HIV-1 Gag Vaccination.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
127. KUMAR A , Zloza A, Moon RT, Watts J, et al
     Active {beta}-catenin signaling is an inhibitory pathway of HIV replication in peripheral blood mononuclear cells.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
128. REHR M , Cahenzli J, Haas A, Price DA, et al
     Emergence of polyfunctional CD8+ T cells after prolonged suppression of HIV replication by antiretroviral therapy.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
129. SCHUMACHER AJ , Hache G, Macduff DA, Brown WL, et al
     The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD and HIV-1 restriction.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
130. MOOIJ P , Balla-Jhagjhoorsingh SS, Koopman G, Beenhakker N, et al
     Differential CD4+ versus CD8+ T-cell responses elicited by different Poxvirus-based HIV-1 vaccine candidates provide comparable efficacy in primates.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
131. JOSEPH A , Zheng JH, Follenzi A, Dilorenzo T, et al
     Lentiviral Vectors Encoding HIV-1-specific TCR Genes Efficiently Convert Peripheral Blood CD8 T Lymphocytes Into Cytotoxic T Lymphocytes With Potent In Vitro and In Vivo HIV-1-specific Inhibitory Activity.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
132. TURK G , Gherardi MM, Laufer N, Saracco M, et al
     MAGNITUDE, BREADTH AND FUNCTIONAL PROFILE OF T-CELL RESPONSES DURING HIV PRIMARY INFECTION WITH B AND BF VIRAL VARIANTS.
     J Virol. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
133. VALENTINE LE , Piaskowski SM, Rakasz EG, Henry NL, et al
     Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences.
     J Virol. 2008;82:575-81.
     PubMed     Related articles    Abstract available
     
     
     December 2007
134. ABBINK TE , Berkhout B
     RNA structure modulates splicing efficiency at the HIV-1 major splice donor.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
135. HUARD S , Elder RT, Liang D, Li G, et al
     HIV-1 Vpr induces cell cycle G2 arrest through Srk1/MK2-mediated phosphorylation of Cdc25.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
136. KING SR , Duggal NK, Ndongmo CB, Pacut C, et al
     Pseudodiploid genome organization aids full-length HIV-1 DNA synthesis.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
137. RAUCH S , Pulkkinen K, Saksela K, Fackler OT, et al
     HIV-1 Nef Recruits the Guanine Exchange Factor Vav1 via an Unexpected Interface into Plasma Membrane Microdomains for Association with PAK2 Activity.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
138. LUTTGE BG , Shehu-Xhilaga M, Demirov DG, Adamson CS, et al
     MOLECULAR CHARACTERIZATION OF FELINE IMMUNODEFICIENCY VIRUS BUDDING.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
139. LEBLANC JJ , Perez O, Hope TJ
     Probing the Structural States of HIV-1 Pr55gag Using Monoclonal Antibodies.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
140. JIN Q , Agrawal L, Meyer L, Tubiana R, et al
     CCR5{Delta}32 59537-G/A Promoter Polymorphism Is Associated With Low Translational Efficiency and The Loss of The CCR5{Delta}32 Protective Effects.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
141. KITAYAMA H , Miura Y, Ando Y, Hoshino S, et al
     Human Immunodeficiency Virus Type-1 Vpr Inhibits Axonal Outgrowth through Induction of Mitochondrial Dysfunction.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
142. CHUKKAPALLI V , Hogue IB, Boyko V, Hu WS, et al
     Interaction between HIV-1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient Gag-membrane binding.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
143. GRAY ES , Moore PL, Bibollet-Ruche F, Li H, et al
     4E10 Resistant Variants in an HIV-1 Subtype C Infected Individual with an Anti-MPER Neutralizing Antibody Response.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
144. REN W , Qu X, Li W, Han Z, et al
     Difference in receptor usage between SARS coronavirus and SARS-like coronavirus of bat origin.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
145. GOLDSCHMIDT V , Ciuffi A, Ortiz M, Brawand D, et al
     Anti-Retroviral Activity of Ancestral TRIM5{alpha}
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
146. SEDAGHAT AR , German J, Teslovich TM, Cofrancesco J Jr, et al
     Chronic CD4+ T cell Activation and Depletion in HIV-1 Infection: Type I Interferon-Mediated Disruption of T Cell Dynamics.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
147. VON EIJE KJ , Ter Brake O, Berkhout B
     HIV-1 escape is restricted when conserved genome sequences are targeted by RNA interference.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
148. ANDERSON JL , Campbell EM, Figueiredo A, Hope TJ, et al
     Heat shock perturbs TRIM5{alpha} restriction of HIV-1.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
149. GANDHI SK , Siliciano JD, Bailey JR, Siliciano RF, et al
     The role of APOBEC3G/F-mediated hypermutation in the control of HIV-1 in Elite Suppressors.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
150. MOTOMURA K , Chen J, Hu WS
     Genetic Recombination between Human Immunodeficiency Virus Type 1 (HIV-1) and HIV-2, Two Distinct Human Lentiviruses.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
151. NOVIELLO CM , Benichou S, Guatelli JC
     Cooperative binding of the MHC-I cytoplasmic domain and HIV-1 Nef to the endosomal AP-1 complex via its {micro} subunit.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
152. LOFFREDO JT , Bean AT, Beal DR, Leon EJ, et al
     Patterns of CD8+ Immunodominance May Influence the Ability of Mamu-B*08-positive Macaques to Naturally Control SIVmac239 Replication.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
153. LEE EG , Kuppers D, Horn M, Roy J, et al
     A premature termination codon mutation at the C-terminus of foamy virus Gag down-regulates the levels of spliced pol mRNA.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
154. MOORE PL , Gray ES, Choge IA, Ranchobe N, et al
     THE C3-V4 REGION IS A MAJOR TARGET OF AUTOLOGOUS NEUTRALIZING ANTIBODIES IN HIV-1 SUBTYPE C INFECTION.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
155. SIVAKUMAR R , Sharma-Walia N, Raghu H, Veettil MV, et al
     Kaposi's Sarcoma Associated Herpesvirus (KSHV) Induces Sustained levels of Vascular Endothelial Growth Factors -A and -C Early During In Vitro Infection of Human Microvascular Dermal Endothelial Cells: Biological Implications.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
156. PETERS HO , Mendoza MG, Capina RE, Luo M, et al
     An Integrative Bioinformatic Approach in Studying Escape Mutations in HIV-1 gag in the Pumwani Sex Worker Cohort.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     November 2007
157. KOSUB DA , Lehrman G, Milush JM, Zhou D, et al
     Gamma/Delta T Cell Functional Responses Differ Following Pathogenic HIV and Non-Pathogenic SIV Infections.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
158. GASKILL PJ , Zandonatti M, Gilmartin T, Head SR, et al
     Macrophage Derived SIV Exhibits Enhanced Infectivity by Comparison with T Cell Derived Virus.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
159. WARRILOW D , Meredith L, Davis A, Burrell C, et al
     Cell Factors Stimulate HIV-1 Reverse Transcription In Vitro.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
160. LINDWASSER OW , Smith WJ, Chaudhuri R, Yang P, et al
     A Diacidic Motif in HIV-1 Nef is a Novel Determinant of Binding to AP2.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
161. POPOV S , Popova E, Inoue M, Gottlinger HG, et al
     Human Immunodeficiency Virus Type 1 Gag Engages the Bro1 Domain of ALIX/AIP1 through Nucleocapsid.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
162. MANDAL D , Feng Z, Stoltzfus CM
     GAG PROCESSING DEFECT OF HIV-1 INTEGRASE E246 AND G247 MUTANTS IS CAUSED BY ACTIVATION OF AN OVERLAPPING 5' SPLICE SITE.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
163. FASCHINGER A , Rouault F, Sollner J, Lukas A, et al
     Mouse Mammary Tumor Virus Integration Site Selection in Human and Mouse Genomes.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
164. TRKOLA A , Kuster H, Rusert P, von Wyl V, et al
     In vivo efficacy of HIV neutralizing antibodies: Estimates for protective titers.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
165. CHENG X , Belshan M, Ratner L
     Hsp40 facilitates HIV-2 Vpx-Mediated Preintegration Complex Nuclear Import.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
166. BROWNE EP , Littman DR
     Species specific restriction of Apobec3 mediated hypermutation.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
167. PATEL MB , Hoffman NG, Swanstrom R
     Subtype-Specific Conformational Differences Within the V3 Region of Subtype B and Subtype C Human Immunodeficiency Virus Type 1 Env Protein.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
168. CHING LK , Vlachogiannis G, Bosch KA, Stamatatos L, et al
     The first hypervariable region of the gp120 Env glycoprotein defines the neutralizing susceptibility of heterologous HIV-1 isolates to neutralizing antibodies elicited by the SF162gp140 immunogen.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
169. GIRALDO-VELA JP , Rudersdorf R, Chung C, Qi Y, et al
     The Major Histocompatibility Complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of SIV-infected rhesus macaque elite controllers.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
170. SCHOENLY KA , Weiner DB
     HIV-1 Vaccine Development: Recent Advances in the CTL Platform "Spotty Business"
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
171. SATO K , Aoki J, Misawa N, Daikoku E, et al
     Modulation of Human Immunodeficiency Virus Type 1 Infectivity through Incorporation of Tetraspanin Proteins.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
172. OH J , McWilliams MJ, Julias JG, Hughes SH, et al
     Mutations in the U5 adjacent to the primer binding site affect tRNA cleavage by HIV-1 RT in vivo.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
173. SACHA JB , Chung C, Reed J, Jonas AK, et al
     Pol-specific CD8+ T cells recognize simian immunodeficiency virus-infected cells prior to Nef-mediated major histocompatibility complex class I downregulation.
     J Virol. 2007;81:11703-12.
     PubMed     Related articles    Abstract available
     
     
     October 2007
174. MARIN M , Golem S, Rose KM, Kozak SL, et al
     HIV-1 Vif Functionally Interacts with Diverse APOBEC3 Cytidine Deaminases and Moves with Them Between Cytoplasmic Sites of mRNA Metabolism.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
175. NOLAN KM , Jordan AP, Hoxie JA
     Effects of Partial Deletions within the HIV-1 V3 Loop on Coreceptor Tropism and Sensitivity to Entry Inhibitors.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
176. SEN P , Charini WA, Subbramanian RA, Manuel ER, et al
     Clonal focusing of epitope-specific CD8+ T lymphocytes in rhesus monkeys following vaccination and simian-human immunodeficiency virus challenge.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
177. SHIMURA K , Kodama E, Sakagami Y, Matsuzaki Y, et al
     Broad Anti-Retroviral Activity and Resistance Profile of a Novel Human Immunodeficiency Virus Integrase Inhibitor, Elvitegravir (JTK-303/GS-9137).
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
178. PACHECO B , Basmaciogullari S, Labonte JA, Xiang SH, et al
     Adaptation of the HIV-1 Envelope Glycoproteins to New World Monkey Receptors.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
179. ROBERTSON SJ , Ammann CG, Messer RJ, Carmody AB, et al
     Suppression of acute anti-Friend virus CD8+ T cell responses by co-infection with lactate dehydrogenase-elevating virus.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
180. SANKARAN S , George MD, Reay E, Guadalupe M, et al
     Rapid onset of intestinal epithelial barrier dysfunction in primary HIV infection is driven by imbalance between immune response and mucosal repair and regeneration.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
181. FUJIWARA M , Tanuma J, Koizumi H, Kawashima Y, et al
     Different Ability of Escape Mutant-Specific Cytotoxic T Cells to Suppress Replication of Escape Mutant and Wild-type HIV-1 in New Hosts.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
182. LI Y , Cleveland B, Klots I, Travis B, et al
     Removal of a single N-linked glycan in HIV-1 gp120 results in enhanced ability to induce neutralizing antibody responses.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
183. HUSSAIN A , Wesley C, Khalid M, Chaudhry A, et al
     The HIV-I Vpu protein interacts with CD74 and modulates major histocompatibility complex II presentation.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
184. VIRGEN CA , Hatziioannou T
     Antiretroviral activity and Vif sensitivity of rhesus macaque APOBEC3 proteins.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
185. COOPER D , Wright KJ, Calderon PC, Guo M, et al
     Attenuation of Recombinant Vesicular Stomatitis Virus HIV-1 Vaccine Vectors by Gene Translocations and G Gene Truncation Reduces Neurovirulence and Enhances Immunogenicity in Mice.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
186. LAKHASHE SK , Thakar MR, Bharucha KE, Paranjape RS, et al
     Quantitation of HLA (Human Leukocyte Antigen) proteins incorporated by HIV-1 and assessment of neutralizing activity of anti-HLA antibodies.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
187. DEGOTTARDI MQ , Lew SK, Piatak M Jr, Jia B, et al
     Comparison of Plasma Viremia and Antibody Responses in Macaques Inoculated with Envelope Variants of Single-Cycle SIV Differing in Infectivity and Cellular Tropism.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
188. ALAM SM , Scearce RM, Parks R, Plonk K, et al
     HIV-1 gp41 Antibodies That Mask Membrane Proximal Region Epitopes: Antibody Binding Kinetics, Induction And Potential For Regulation in Acute Infection.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
189. ALVAREZ R , Reading J, King DF, Hayes M, et al
     WFDC1/ps20 is a novel innate immunomodulatory signature protein of HIV permissive CD4+ CD45RO+ memory T-cells that promotes infection by up-regulating CD54 integrin expression and is elevated in HIV-1 infection.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
190. CAO J , McNevin J, McSweyn M, Liu Y, et al
     Novel CTL Escape by a Three Amino Acid Insertion in HIV-1 p6Pol and p6Gag Late Domain Associated with Drug Resistance.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
191. PLESA G , Dai J, Baytop C, Riley JL, et al
     Addition of deoxynucleosides enhances HIV-1 integration and 2LTR formation in resting CD4+ T cells.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
192. DIERYNCK I , De Wit M, Gustin E, Keuleers I, et al
     Binding kinetics of darunavir to HIV-1 protease explain the potent antiviral activity and high genetic barrier.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
193. POTTER SJ , Lacabaratz C, Lambotte O, Perez-Patrigeon S, et al
     Preserved central memory and activated effector memory CD4+ T cell subsets in HIV controllers: an ANRS EP36 study.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
194. MUNCH J , Rajan D, Schindler M, Specht A, et al
     Nef-mediated Enhancement of Virion Infectivity and Stimulation of Viral Replication are Fundamental Properties of Primate Lentiviruses.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
195. MIYAGI E , Opi S, Takeuchi H, Khan M, et al
     Enzymatically Active APOBEC3G is Required for Efficient Inhibition of HIV-1.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
196. DUVALL MG , Lore K, Blaak H, Ambrozak DA, et al
     Dendritic Cells Are Less Susceptible to HIV-2 Than HIV-1 Infection.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
197. LJUNGBERG K , Whitmore AC, Fluet ME, Moran TP, et al
     Increased immunogenicity of a DNA-launched VEE-based replicon DNA vaccine.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
198. SABATTE J , Ceballos A, Raiden S, Vermeulen M, et al
     Human seminal plasma abrogates the capture and transmission of HIV-1 to T CD4+ cells mediated by DC-SIGN.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
199. JOLLY C , Mitar I, Sattentau QJ
     Adhesion molecule interactions facilitate human immunodeficiency virus type-1-induced virological synapse formation between T cells.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
200. POON AF , Kosakovsky Pond SL, Richman DD, Frost SD, et al
     Mapping protease inhibitor resistance to HIV-1 sequence polymorphisms within patients.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
201. KARLSSON I , Malleret B, Brochard P, Delache B, et al
     Dynamics of T cell responses and memory T cells during primary SIV infection in cynomolgus macaques.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
202. GIANNECCHINI S , Pistello M, Isola P, Matteucci D, et al
     Role of Env in resistance of feline immunodeficiency virus (FIV)-infected cats to superinfection by a second FIV strain as determined by using a chimeric virus.
     J Virol. 2007;81:10474-85.
     PubMed     Related articles    Abstract available
     
     
     
203. DIAZ-GRIFFERO F , Kar A, Perron M, Xiang SH, et al
     Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5alpha B-box 2 domain.
     J Virol. 2007;81:10362-78.
     PubMed     Related articles    Abstract available
     
     
     
204. LAIRD ME , Desrosiers RC
     Infectivity and neutralization of simian immunodeficiency virus with FLAG epitope insertion in gp120 variable loops.
     J Virol. 2007;81:10838-48.
     PubMed     Related articles    Abstract available
     
     
     September 2007
205. MEHLE A , Wilson H, Zhang C, Brazier AJ, et al
     Identification of an APOBEC3G Binding Site in HIV-1 Vif and Inhibitors of Vif-APOBEC3G Binding.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
206. MONCEAUX V , Viollet L, Petit F, Cumont MC, et al
     CD4+CCR5+ T-cell dynamics during SIV infection of Chinese rhesus macaques.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
207. PEUT V , Kent SJ
     Utility of HIV-1 Envelope as a T Cell Immunogen.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
208. GIFFORD RJ , de Oliveira T, Rambaut A, Pybus OG, et al
     Phylogenetic Surveillance of Viral Genetic Diversity and the Evolving Molecular Epidemiology of HIV-1.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
209. KARLSSON I , Malleret B, Brochard P, Delache B, et al
     FoxP3+CD25+CD8+ T-cell induction during primary SIV infection in cynomolgus macaques correlates with low CD4+ T-cell activation and high viral load.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
210. GELDMACHER C , Gray C, Nason M, Currier JR, et al
     A high viral burden predicts the loss of CD8 T cell responses specific for subdominant Gag epitopes during chronic HIV infection.
     J Virol. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
211. GUSTCHINA E , Louis JM, Lam SN, Bewley CA, et al
     A Monoclonal Fab Derived From a Human Non-Immune Phage Library Reveals a New Epitope on gp41 and Neutralizes Diverse HIV-1 Strains.
     J Virol. 2007;.